C94.01
Acute erythroid leukemia, in remission
Clinical Classification Guidelines
Medical Intelligence & Overview
Acute erythroid leukemia, classified under ICD-10 code C94.01, is a rare type of blood cancer that affects the bone marrow's ability to produce healthy red blood cells. When this condition is in remission, it indicates that symptoms are reduced or absent following treatment. This summary provides a patient-friendly explanation of the condition, its causes, symptoms, diagnosis, and management options.
Causes & Symptoms
Clinical Causes: Genetic mutations within the bone marrow cells leading to abnormal cell growth. Previous exposure to chemotherapy or radiation therapy for other cancers. Environmental factors such as exposure to certain chemicals and toxins. Underlying health conditions or genetic predispositions. Progression from other myelodysplastic syndromes or related blood disorders.
Key Symptoms: Weakness and fatigue due to decreased red blood cell production. Shortness of breath, especially during physical activity. Pale skin and mucous membranes. Increased risk of infections because of lowered normal white blood cell counts. Easy bruising or bleeding due to low platelet counts. Fainting or dizziness in severe cases. Unexplained weight loss and persistent fevers in some cases.
Diagnostic & Treatment
Diagnosis Path: - Additional blood tests to rule out infections or other causes of symptoms.
Treatment Protocols: - Targeted therapies or clinical trials exploring newer treatments for this rare leukemia subtype.
Clinical Advice & FAQs
Billing Guidance
Is C94.01 a billable ICD-10 code?
Yes, C94.01 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C94.01?
Clinical documentation must specify the nature of Acute erythroid leukemia, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference